These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25028166)

  • 21. Clinical Aspects of Type 3 Long-QT Syndrome: An International Multicenter Study.
    Wilde AA; Moss AJ; Kaufman ES; Shimizu W; Peterson DR; Benhorin J; Lopes C; Towbin JA; Spazzolini C; Crotti L; Zareba W; Goldenberg I; Kanters JK; Robinson JL; Qi M; Hofman N; Tester DJ; Bezzina CR; Alders M; Aiba T; Kamakura S; Miyamoto Y; Andrews ML; McNitt S; Polonsky B; Schwartz PJ; Ackerman MJ
    Circulation; 2016 Sep; 134(12):872-82. PubMed ID: 27566755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Verapamil decreases ventricular tachyarrhythmias in a patient with Timothy syndrome (LQT8).
    Jacobs A; Knight BP; McDonald KT; Burke MC
    Heart Rhythm; 2006 Aug; 3(8):967-70. PubMed ID: 16876748
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical and genetic profile of congenital long QT syndrome in Hong Kong: a 20-year experience in paediatrics.
    Kwok SY; Liu AP; Chan CY; Lun KS; Fung JL; Mak CC; Chung BH; Yung TC
    Hong Kong Med J; 2018 Dec; 24(6):561-570. PubMed ID: 30530868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experience with bisoprolol in long-QT1 and long-QT2 syndrome.
    Steinberg C; Padfield GJ; Al-Sabeq B; Adler A; Yeung-Lai-Wah JA; Kerr CR; Deyell MW; Andrade JG; Bennett MT; Yee R; Klein GJ; Green M; Laksman ZW; Krahn AD; Chakrabarti S
    J Interv Card Electrophysiol; 2016 Nov; 47(2):163-170. PubMed ID: 27394160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mexiletine Shortens the QT Interval in Patients With Potassium Channel-Mediated Type 2 Long QT Syndrome.
    Bos JM; Crotti L; Rohatgi RK; Castelletti S; Dagradi F; Schwartz PJ; Ackerman MJ
    Circ Arrhythm Electrophysiol; 2019 May; 12(5):e007280. PubMed ID: 31006312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of verapamil and propranolol on early afterdepolarizations and ventricular arrhythmias induced by epinephrine in congenital long QT syndrome.
    Shimizu W; Ohe T; Kurita T; Kawade M; Arakaki Y; Aihara N; Kamakura S; Kamiya T; Shimomura K
    J Am Coll Cardiol; 1995 Nov; 26(5):1299-309. PubMed ID: 7594047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of beta-adrenergic antagonists on the QT measurements from exercise stress tests in pediatric patients with long QT syndrome.
    Kaltman JR; Ro PS; Stephens P; McBride MG; Cohen MI; Tanel RE; Vetter VL; Rhodes LA
    Pediatr Cardiol; 2003; 24(6):553-8. PubMed ID: 12947504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-blocker therapy for long QT syndrome and catecholaminergic polymorphic ventricular tachycardia: Are all beta-blockers equivalent?
    Ackerman MJ; Priori SG; Dubin AM; Kowey P; Linker NJ; Slotwiner D; Triedman J; Van Hare GF; Gold MR
    Heart Rhythm; 2017 Jan; 14(1):e41-e44. PubMed ID: 27659101
    [No Abstract]   [Full Text] [Related]  

  • 29. The role of mexiletine in the management of long QT syndrome.
    Li G; Zhang L
    J Electrocardiol; 2018; 51(6):1061-1065. PubMed ID: 30497731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful treatment of long QT syndrome-induced ventricular tachycardia with esmolol.
    Balcells J; Rodríguez M; Pujol M; Iglesias J
    Pediatr Cardiol; 2004; 25(2):160-2. PubMed ID: 15046104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long QT syndrome in adults.
    Sauer AJ; Moss AJ; McNitt S; Peterson DR; Zareba W; Robinson JL; Qi M; Goldenberg I; Hobbs JB; Ackerman MJ; Benhorin J; Hall WJ; Kaufman ES; Locati EH; Napolitano C; Priori SG; Schwartz PJ; Towbin JA; Vincent GM; Zhang L
    J Am Coll Cardiol; 2007 Jan; 49(3):329-37. PubMed ID: 17239714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hereditary long QT syndrome: our own experience].
    Majewski J; Lelakowski J
    Wiad Lek; 1999; 52(1-2):67-73. PubMed ID: 10335128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electromechanical window negativity in genotyped long-QT syndrome patients: relation to arrhythmia risk.
    ter Bekke RM; Haugaa KH; van den Wijngaard A; Bos JM; Ackerman MJ; Edvardsen T; Volders PG
    Eur Heart J; 2015 Jan; 36(3):179-86. PubMed ID: 25205533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atrial Arrhythmias in long-QT syndrome under daily life conditions: a nested case control study.
    Zellerhoff S; Pistulli R; Mönnig G; Hinterseer M; Beckmann BM; Köbe J; Steinbeck G; Kääb S; Haverkamp W; Fabritz L; Gradaus R; Breithardt G; Schulze-Bahr E; Böcker D; Kirchhof P
    J Cardiovasc Electrophysiol; 2009 Apr; 20(4):401-7. PubMed ID: 19017345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. β-Blocker Adherence in Familial Long QT Syndrome.
    Waddell-Smith KE; Li J; Smith W; Crawford J; Skinner JR;
    Circ Arrhythm Electrophysiol; 2016 Aug; 9(8):. PubMed ID: 27516460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias.
    Schwartz PJ; Priori SG; Spazzolini C; Moss AJ; Vincent GM; Napolitano C; Denjoy I; Guicheney P; Breithardt G; Keating MT; Towbin JA; Beggs AH; Brink P; Wilde AA; Toivonen L; Zareba W; Robinson JL; Timothy KW; Corfield V; Wattanasirichaigoon D; Corbett C; Haverkamp W; Schulze-Bahr E; Lehmann MH; Schwartz K; Coumel P; Bloise R
    Circulation; 2001 Jan; 103(1):89-95. PubMed ID: 11136691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dispersion of the QT interval. A marker of therapeutic efficacy in the idiopathic long QT syndrome.
    Priori SG; Napolitano C; Diehl L; Schwartz PJ
    Circulation; 1994 Apr; 89(4):1681-9. PubMed ID: 7908611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The long QT syndrome in children. An international study of 287 patients.
    Garson A; Dick M; Fournier A; Gillette PC; Hamilton R; Kugler JD; van Hare GF; Vetter V; Vick GW
    Circulation; 1993 Jun; 87(6):1866-72. PubMed ID: 8099317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Value of the "Standing Test" in the Diagnosis and Evaluation of Beta-blocker Therapy Response in Long QT Syndrome.
    Muñoz-Esparza C; Zorio E; Domingo Valero D; Peñafiel-Verdú P; Sánchez-Muñoz JJ; García-Molina E; Sabater M; Navarro M; San-Román I; Pérez I; Santos JJ; Cabañas-Perianes V; Valdés M; Pascual D; García-Alberola A; Gimeno Blanes JR
    Rev Esp Cardiol (Engl Ed); 2017 Nov; 70(11):907-914. PubMed ID: 28233664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genotype-specific risk stratification and management of patients with long QT syndrome.
    Barsheshet A; Dotsenko O; Goldenberg I
    Ann Noninvasive Electrocardiol; 2013 Nov; 18(6):499-509. PubMed ID: 24206565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.